i-SENS, Inc.

i-SENS, Inc.

i-SENS is a global company dedicated to improving the lives of people with diabetes and those who care for them.

Founded 2000

Korea South 106 employees Series A Total: $11.80B Health Care, Manufacturing +1

i-SENS, Inc. is a global company established in 2000 with a mission to enhance the lives of individuals with diabetes and their caretakers. The company's flagship brand, CareSens®, is renowned worldwide for its rapid and highly precise blood glucose testing outcomes. With an annual production capacity of 2.2 billion test strips, i-SENS operates efficient manufacturing facilities in South Korea and China and exports to over 110 countries, including the USA, Japan, and Europe. Notably, the company holds the top market share in South Korea. In addition to its blood glucose monitoring products, i-SENS collaborates closely with healthcare professionals to offer practical Point-of-Care Testing (POCT) devices such as Electrolyte and Blood Gas Analyzers. Furthermore, the company is poised to launch Continuous Glucose Monitoring (CGM) devices in the near future, showcasing its commitment to innovation and advancement in diabetes care. The most recent investment in i-SENS, Inc. was a KRW11.80B Series A - I investment, which took place on 04 November 2021. The investors involved in this funding round include Korea Investment Partners, DSC Investment, and Mirae Asset Venture Investment. With its strong market presence, focus on innovation, and backing from prominent investors, i-SENS, Inc. is positioned as a frontrunner in the diabetes care industry.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A I	KRW11.80B	3	Korea Investment Partners, DSC Investment +1	04 Nov 2021
Venture Round I	Undisclosed	1	STIC Ventures	01 Jan 2008

Funding Stage

Amount

Investors

Lead Investors

Date

Series A I

KRW11.80B

Korea Investment Partners, DSC Investment +1

04 Nov 2021

Venture Round I

Undisclosed

STIC Ventures

01 Jan 2008

FAQ About i-SENS, Inc.

i-SENS is a global company dedicated to improving the lives of people with diabetes and those who care for them.

i-SENS, Inc. was founded in 2000.

i-SENS, Inc. is headquartered in Korea South.

i-SENS, Inc. operates in Health Care, Manufacturing and Medical Devices. Its work centres on Diabetes Management, Global Exporter, POCT Devices and Blood Glucose Monitoring System.

i-SENS, Inc. has approximately 106 employees.

i-SENS, Inc. has completed 2 funding rounds, raising a total of $11.80B. The latest funding stage is Series A.

Top alternatives and competitors to i-SENS, Inc. include Intuity Medical, Inc., EKF Diagnostics, ARKRAY USA, Senseonics, Incorporated, MicroTech Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

i-SENS, Inc. and Intuity Medical, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About i-SENS, Inc.

Funding Rounds & Investors (2)

i-SENS, Inc. Alternatives & Competitors

FAQ About i-SENS, Inc.